Across TCGA pan-cancer cohorts, LINC00299 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LINC00299 data layer compared with 23 for mass-spec protein.
The strongest signal is observed in thymoma (THYM), where higher LINC00299 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00299 expression acts as an unfavorable survival marker.
THYM and UCEC are the cancer types where LINC00299 Mutation most reproducibly stratifies survival.